Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular Hypertension

PHASE3CompletedINTERVENTIONAL

Enrollment

105

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions

GlaucomaOcular Hypertension

Interventions

DRUG

BETOPTIC S (betaxolol HCl)

betaxolol HC)

DRUG

Timolol Gel-forming Solution (TGFS)

timolol maleate 0.25% and 0.5%

Trial Locations (1)

Alcon Call Center, Fort Worth